The drug aims to address obesity by enhancing fat loss and controlling appetite through its glucagon-like peptide-1 receptor and glucagon receptor activation. Preclinical studies suggest promising ...

Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development ...

Campus Chemical Instrument Center, Mass Spectrometry & Proteomics Facility, The Ohio State University, Columbus, USA ...

A 2024 study found that dysgeusia (a broad term used to describe distorted taste) is a common symptom that persists for more ...

It's a regular occurrence when taking our canine pals for drizzly walks and summer swims. But until recently, the biology ...

Nearly 4 million patients with chronic obstructive pulmonary disease (COPD) or asthma die each year, mostly from severe acute exacerbations.1 For the past 60 years, systemic corticosteroids have been ...

The GLM India founder Viki Vaurora speaks about the need to legalise cannabis for therapeutic use in healthcare and to ...

A study appearing in Nature Neuroscience has linked distinct neural and behavioral characteristics in autism spectrum ...

What is neuroplasticity and how can the use of hypnotherapy to form new connections help us make beneficial long-term changes ...

A potential new treatment for Alzheimer’s disease may come in the form of a nasal spray. Researchers in Italy have discovered ...

Shares in Amgen fell on Tuesday after they announced the results of a trial for their weight loss drug MariTide.

Corcept Therapeutics specializes in cortisol-modulating drugs. Click here to read why CORT stock offers investment potential.